Francis Cuss Insider Profile
11 Followers
Francis Cuss, EVP & CSO at Bristol-Myers Squibb, holds 10.00K shares in Rubius Therapeutics (Ticker: RUBY), holds 321.90K shares in Bristol-Myers Squibb (Ticker: BMY), holds ― shares in Mural Oncology Plc (Ticker: MURA). Most recently, Francis Cuss Bought ― shares of Rubius Therapeutics on Jul 23, 2018 for an estimated value of $230.00K.
Francis Cuss's Trading History
| RUBYRubius Therapeutics | Jul 23, 2018 | ― | Informative Buy | 230.00K | $570.00 | |
| BMYBristol-Myers Squibb | Mar 14, 2017 | EVP & CSO | Uninformative Buy | 1.88M | $20.26M | |
| MURAMural Oncology Plc | ― | ― | ― | ― |
You May Also Like
Francis Cuss insider profile FAQ
What is the percentage of profitable transactions made by Francis Cuss?
The percentage of profitable transactions made by Francis Cuss is 25%.
What is the average return per transaction made by Francis Cuss?
The average return per transaction made by Francis Cuss is -16.60%.
What stocks does Francis Cuss hold?
Francis Cuss holds: BMY, RUBY, MURA stocks.
What was Francis Cuss’s latest transaction?
Francis Cuss’s latest transaction was an Informative Buy of $230.00K.
What was Francis Cuss's most profitable transaction?
Francis Cuss’s most profitable transaction was an Informative Sell of BMY stock on March 17, 2015. The return on the trade was 6.90%.
What is Francis Cuss's role in Bristol-Myers Squibb?
Francis Cuss's role in Bristol-Myers Squibb is EVP & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
